Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders.
Saved in:
| Title: | Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders. |
|---|---|
| Authors: | Zhong J; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA., Song R; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA., Kerrouche N; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA., Yu X; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA., Levin Y; Synaptic Bio, Inc., Wilmington, DE, USA., Mor A; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA. am5121@columbia.edu.; Division of Rheumatology, Department of Medicine, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA. am5121@columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, 630 W 168 Street, Suite 3-350-G, New York, NY, 10032, USA. am5121@columbia.edu. |
| Source: | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 567-580. Date of Electronic Publication: 2026 May 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
